Harvard Bioscience HBIO Q1 2026 earnings
Reported May 12, 2026 · Before market open
Revenue estimate$21.2M
EPS estimate-$0.62
Next report
Aug 10, 2026 (In 4 weeks)Revenue estimate$21.5M
EPS estimate-$0.21
Versus estimates
Revenue
Diluted EPS
Ask the moment Harvard Bioscience reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Harvard Bioscience report Q1 2026 earnings?
- Harvard Bioscience (HBIO) reported Q1 2026 earnings on May 12, 2026 before market open.
- What were Harvard Bioscience's Q1 2026 revenue and EPS?
- Harvard Bioscience reported revenue of $20.8M and diluted EPS of $-0.33 for Q1 2026.
- Did Harvard Bioscience beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $21.2M by $445.0K. EPS beat the consensus estimate of $-0.62 by $0.29.
- How did Harvard Bioscience's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 4.7% from $21.8M a year earlier and diluted EPS declined 3200.0% from $-0.01.
- Where can I find Harvard Bioscience's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001171843-26-003270) and the 10-Q periodic report (0001171843-26-003311) directly on SEC EDGAR. The filing index links above go to sec.gov.